The ultrastructure of articular cartilage is unique: chondrocytes are sparsely distributed within the surrounding matrix, maintaining minimal cell to cell contact. The interaction between cells, collagen framework, aggrecan, and fluid constitutes the complex ultrastructure of hyaline cartilage making its replacement or reproduction difficult. 1 New, ambitious regenerative procedures are emerging as potential therapeutic options for the treatment of chondral lesions, aiming to recreate a hyaline-like tissue thus restoring a biologically and biomechanically valid articular surface with durable clinical results.Autologous chondrocyte implantation (ACI) has been introduced in 1987 in Sweden, and in 1994 Brittberg et al 2 published the first clinical report showing satisfactory results for isolated femoral condyle lesions. Since then, several studies followed documenting both the production of a hyaline-like articular surface and good results in the majority of the patients at medium-long follow-up. Treatment indications have been broadened 3-5 and this cell-based technique has gained increasing interest worldwide. 6-10 The development of bioengineering technology further improved this regenerative treatment approach: essentially, transplanting biodegradable molecules that are used as temporary scaffolds for the growth of living cells. 11 Matrix-assisted ACI (MACI) techniques have been introduced in the clinical practice one decade ago, showing good clinical results while at the same time overcoming most of the concerns related to the firstgeneration ACI. 12 The use of cell-loaded scaffolds to regenerate a cartilage-like tissue presents advantages from both the biological and surgical point of view, thus aiming to further optimize this regenerative surgical procedure.
Surgical TechniqueThe surgical technique of both ACI and MACI consists of two steps. The first one is an arthroscopic procedure where a Abstract Regenerative procedures aim to recreate a hyaline-like tissue, thus restoring a biologically and biomechanically valid articular surface with durable clinical results. Autologous chondrocyte implantation (ACI) has been developed two decades ago, and both the production of a hyaline-like articular surface and a satisfactory clinical outcome have been documented at medium-long follow-up. Bioengineering technology further improved this regenerative treatment approach to include matrix-assisted ACI (MACI) techniques. These procedures have been introduced in the clinical practice one decade ago, showing similar results while at the same time overcoming most of the concerns related to the first-generation ACI. The use of scaffolds to create a cartilage-like tissue in a three-dimensional culture system allows for the optimization of the procedure from both the biological and surgical point of view. However, despite thousands of treated patients and many published studies suggesting good clinical results and durability of these procedures, the properties of healthy, normal articular cartilage are still unmatched by an...